Sign in

NCT06621524Active, not recruiting

EucaLimus Post-Market Registry

Coronary Angioplasty With Sirolimus Drug-coated Stent System to Treat Patients With Symptomatic Ischemic Coronary Heart Disease: a PMCF Study.

Source: ClinicalTrials.gov · Last updated 11 Mar 2026

Brief summary (registry, in English)

To collect post marketing surveillance data on consecutive patients with coronary heart disease intended to be or treated by the Eucalimus sirolimus eluting PTCA stent when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Eucalimus PTCA stent in routine clinical practice.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
251 (actual)
First submitted
27 Sept 2024
Start date
14 Mar 2025
Primary completion date
Jan 2027
Lead sponsor
OrbusNeich
NCT number
NCT06621524

What you commit to

  • Study type: Observational
  • Participants enrolled: 251
  • From 14 Mar 2025 to the primary completion date, Jan 2027
  • 10 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients are excluded from registration if ANY of the following conditions apply:
    • High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
    • Currently participating in another investigational drug or device study in which a routine angiographic follow-up is planned
    • A life expectancy of \<1year
    • Explicit refusal of participation in the registry

Who the study is looking for

  • Consecutive patients intended to be, or treated by EucaLimus as per physicians' decision and according to Instructions for Use (IFU) in the setting of routine clinical care are entered into the registry.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (10)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Krajská nemocnice Liberec
Coordinator of this site? Confirm its status
LiberecCzechiaUnknown status
Motol University Hospital
Coordinator of this site? Confirm its status
PragueCzechiaUnknown status
Hospital de la Santa Creu i Sant Pau
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital Universitario Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital Universitario Reina Sofia
Coordinator of this site? Confirm its status
CórdobaSpainUnknown status
Bellvitge University Hospital
Coordinator of this site? Confirm its status
L'hospitalet De LlobregatSpainUnknown status
Hospital Universitario Lucus Augusti
Coordinator of this site? Confirm its status
LugoSpainUnknown status
Complejo Hospitalario Universitario de Canarias
Coordinator of this site? Confirm its status
San Cristóbal de La LagunaSpainUnknown status
Hospital Universitario Joan XXIII
Coordinator of this site? Confirm its status
TarragonaSpainUnknown status
Institut Jantung Negara
Coordinator of this site? Confirm its status
Kuala LumpurMalaysiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.